Skip to main content
SpringerLink
Log in

Growth, morphologic, and invasive characteristics of early and late passages of a human endometrial carcinoma cell line (RL95-2)

  • Regular Papers
  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

Summary

Two in vitro passages of a human endometrial adenocarcinoma continuous cell line (RL95-2), an early (subcultured <30 times) and a late passage (subcultured >200 times) have provided an interesting model to study the growth, morphologic, and invasive properties of endometrial tumors. The early passage, which has been shown to be estrogen-receptor positive, has characteristics closely resembling a primary tumor, whereas the estrogen receptor negative late passage exhibits several features of the metastatic phenotype. Compared to the early passage cells, the late passage cells were less serum dependent, formed foci, demonstrated a faster rate of growth (due to their shorter doubling times), and attained higher saturation densities. The late passage cells also displayed an altered morphology which was accompanied by alterations in the distribution of F-actin. Even though early and late passages showed similar invasive potential in an in vitro invasion assay, the late passage cells, by virtue of their several transformed characteristics, maintain distinctive properties compared with their early passage counterparts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Cancer Society. Cancer facts and figures. Atlanta, GA: American Cancer Society; 1989.

    Google Scholar 

  2. Ben-Ze’ev, A. The cytoskeleton in cancer cells. Biochim. Biophys. Acta. 780:197–212; 1985.

    PubMed  CAS  Google Scholar 

  3. Chen, L.; Lindner, H. R.; Lancet, M. Mitogenic action of oestradiol-17β on human myometrial and endometrial cells in long-term culture. J. Endocrinol. 59:87–97; 1973.

    Article  PubMed  CAS  Google Scholar 

  4. Damjanov, I. Ultrastructural pathology of human tumors, vols 1 and 2. Philadelphia: Eden Press; 1980.

    Google Scholar 

  5. Fidler, I. J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res. 38:2651–2660; 1978.

    PubMed  CAS  Google Scholar 

  6. Folkman, J. Tumor angiogenesis. Adv. Cancer Res. 43:175–203; 1985.

    PubMed  CAS  Google Scholar 

  7. Friedman, E.; Verderame, M.; Winawer, S., et al. Actin cytoskeletal organization loss in the benign to malignant tumor transition in cultured human colonic epithelial cells. Cancer Res. 44:3040–3050; 1984.

    PubMed  CAS  Google Scholar 

  8. Gehlsen, K. R.; Wagner, H. N.; Hendrix, M. J. C. Membrane invasion culture system (MICS). Med. Instrum. 18:268–271; 1984.

    PubMed  CAS  Google Scholar 

  9. Ghadially, F. N. Ultrastructural pathology of the cell and matrix, 3rd ed., vols 1 and 2. Boston: Butterworths; 1988.

    Google Scholar 

  10. Ghadially, F. N. Diagnostic electron microscopy of tumors, 2nd ed. Boston: Butterworths; 1985.

    Google Scholar 

  11. Gorodecki, J.; Mortel, R.; Ladda, R. L., et al. Establishment and characterization of a new endometrial cancer cell line (SCRC-1). Am. J. Obstet. Gynecol. 135:671–679; 1979.

    PubMed  CAS  Google Scholar 

  12. Grenman, S. E.; Van Dyke, D. L.; Worsham, M. J., et al. UM-EC-1, a new hypodiploid human cell line derived from a poorly differentiated endometrial cancer. Cancer Res. 48:1864–1873; 1988.

    PubMed  CAS  Google Scholar 

  13. Gusberg, S. B. Current concepts in the control of carcinoma of the endometrium. Cancer J. Clin. 36:245–253; 1986.

    CAS  Google Scholar 

  14. Hendrix, M. J. C.; Seftor, E. A.; Seftor, R. E. B., et al. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett. 38:137–147; 1987.

    Article  PubMed  CAS  Google Scholar 

  15. Hendrix, M. J. C.; Seftor, E. A.; Seftor, R. E. B., et al. Comparison of tumor cell invasion assays: human amnion versus reconstituted basement membrane barriers. Invasion & Metastasis 9:278–297; 1989.

    CAS  Google Scholar 

  16. Heppner, G. H. Tumor heterogeneity. Cancer Res. 44:2259–2265; 1984.

    PubMed  CAS  Google Scholar 

  17. Ishiwata, I.; Nozawa, S.; Inoue, T., et al. Development and characterization of established cell lines from primary and metastatic regions of human endometrial adenocarcinoma. Cancer Res. 37:1777–1785; 1977.

    PubMed  CAS  Google Scholar 

  18. Korc, M.; Padilla, J.; Grosso, D. Epidermal growth factor inhibits the proliferation of a human endometrial carcinoma cell line. J. Clin. Endocrinol. Metab. 62:874–880; 1986.

    PubMed  CAS  Google Scholar 

  19. Korc, M.; Haussler, C. A.; Trookman, N. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. Cancer Res. 47:4909–4914; 1987.

    PubMed  CAS  Google Scholar 

  20. Kruitwagen, R. F. P. M.; Poels, L. G.; Willemsen, W. N. P., et al. ETN-1: A new human endometrial carcinoma cell line producing ascites and distant metastases in nude mice. Int. J. Cancer 43:1098–1103; 1989.

    Article  PubMed  CAS  Google Scholar 

  21. Kuramoto, H.; Tamura, S.; Notake, Y. Establishment of a cell line of human endometrial adenocarcinomain vitro. Am. J. Obstet. Gynecol. 114:1012–1019; 1972.

    PubMed  CAS  Google Scholar 

  22. Kuramoto, H.; Hamono, M. Establishment and characterization of the cell-line of a human endometrial adenocanthoma. Eur. J. Cancer 13:253–259; 1977.

    PubMed  CAS  Google Scholar 

  23. Liotta, L. A. Tumor invasion and metastasis—role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res. 46:1–7; 1986.

    Article  PubMed  CAS  Google Scholar 

  24. Morgan, J. F.; Eng, C. P. The induction of immunoprotection by mouse ascites tumor cells attenuated in tissue culture. Proc. Soc. Exp. Biol. Med. 134:305–308; 1970.

    PubMed  CAS  Google Scholar 

  25. Neri, A.; Nicolson, G. L. Phenotype drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growthin vitro. Int. J. Cancer 28:731–740; 1981.

    Article  PubMed  CAS  Google Scholar 

  26. Nicolson, G. L. Generation of phenotypic diversity and progression in metastatic cells. Cancer Metastasis Rev. 3:25–43; 1984.

    Article  PubMed  CAS  Google Scholar 

  27. Nishida, M.; Kasahara, K.; Kaneko, M., et al. Establishment of a new human endometrial adenocarcinoma cell line. Ishikawa cells, containing estrogen and progesterone receptors. Acta. Obstet. Gynaecol. Jpn. 38:1103–1111; 1985.

    Google Scholar 

  28. Pavlik, E. L.; Katzenellenbogen, B. S. Human endometrial cells in primary tissue culture. J. Clin. Endocrinol. Metab. 47:333–344; 1978.

    PubMed  CAS  Google Scholar 

  29. Poste, G. Cellular heterogeneity in malignant neoplasms and the therapy of metastases. Ann. NY Acad. Sci. 391:34–48; 1983.

    Google Scholar 

  30. Satyaswaroop, P. G.; Bressler, R. S.; De La Pena, M. M., et al. Isolation and culture of human endometrial glands. J. Clin. Endocrinol. & Metab. 48:639–641; 1979.

    Article  CAS  Google Scholar 

  31. Sundareshan, P.; Misiorowski, R. L.; Davis, J. R., et al. Effects of epidermal growth factor on response, morphology, and invasive potential of human endometrial carcinoma cell line RL95-2. Cancer Comm. 3:149–158; 1991.

    CAS  Google Scholar 

  32. Taketani, Y.; Mizuno, M. Characterization of epidermal growth factor (EGF) receptor in human endometrium and its cyclic changes during the menstrual cycle. Arch. Gynaecol. 237:A14.28-03; 1985.

    Google Scholar 

  33. Trent, J. M. Functional and morphological characterization of normal and carcinomatous endometriumin vitro. In: Webber, M. M., ed.In vitro models for cancer research, vol. III. Boca Raton, FL: CRC Press; 1986:153–187.

    Google Scholar 

  34. Varani, J.; Lovett, E. J. Phenotypic stability of murine tumor cellsin vitro andin vivo. JNCI 68:957–962; 1982.

    PubMed  CAS  Google Scholar 

  35. Volk, T.; Gieger, B.; Raz, A. Motility and adhesive properties of high and low metastatic murine neoplastic cells. Cancer Res. 44:811–824; 1984.

    PubMed  CAS  Google Scholar 

  36. Way, D. L.; Grosso, D. S.; Davis, J. R., et al. Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro 19:147–158; 1983.

    Article  PubMed  CAS  Google Scholar 

  37. Welch, D. R.; Tomasovic, S. P. Implications of tumor progression on clinical oncology. Clin. Ex. Metastasis. 3:151–188; 1985.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fox Chase Cancer Center, 7701 Burholme Avenue, Rm. W462, 19111, Philadelphia, PA

    Mary J. C. Hendrix

  2. Department of Anatomy, College of Medicine, University of Arizona, 85724, Tucson, Arizona

    Padma Sundareshan

Authors
  1. Padma Sundareshan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary J. C. Hendrix
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sundareshan, P., Hendrix, M.J.C. Growth, morphologic, and invasive characteristics of early and late passages of a human endometrial carcinoma cell line (RL95-2). In Vitro Cell Dev Biol - Animal 28, 544–552 (1992). https://doi.org/10.1007/BF02634139

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02634139

Key words

Search

Navigation